| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
500488 Stock Overview
Abbott India Limited operates as a pharmaceutical company in India.
Rewards
Risk Analysis
No risks detected for 500488 from our risk checks.
Abbott India Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹19,100.10 |
| 52 Week High | ₹23,902.30 |
| 52 Week Low | ₹13,970.10 |
| Beta | -0.11 |
| 1 Month Change | -4.59% |
| 3 Month Change | -4.69% |
| 1 Year Change | 24.04% |
| 3 Year Change | 146.41% |
| 5 Year Change | 296.63% |
| Change since IPO | 3,250.90% |
Recent News & Updates
Shareholder Returns
| 500488 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.3% | 2.2% | -1.7% |
| 1Y | 24.0% | 15.2% | 42.2% |
Return vs Industry: 500488 exceeded the Indian Pharmaceuticals industry which returned 15.2% over the past year.
Return vs Market: 500488 underperformed the Indian Market which returned 42.2% over the past year.
Price Volatility
| 500488 volatility | |
|---|---|
| 500488 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 3.8% |
Stable Share Price: 500488 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 500488's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | 3,585 | Anil Joseph | https://www.abbott.co.in |
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women’s health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India.
Abbott India Fundamentals Summary
| 500488 fundamental statistics | |
|---|---|
| Market Cap | ₹405.86b |
| Earnings (TTM) | ₹7.18b |
| Revenue (TTM) | ₹46.31b |
56.6x
P/E Ratio8.8x
P/S RatioIs 500488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500488 income statement (TTM) | |
|---|---|
| Revenue | ₹46.31b |
| Cost of Revenue | ₹25.48b |
| Gross Profit | ₹20.83b |
| Expenses | ₹13.65b |
| Earnings | ₹7.18b |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 337.75 |
| Gross Margin | 44.98% |
| Net Profit Margin | 15.50% |
| Debt/Equity Ratio | 0% |
How did 500488 perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield36%
Payout RatioValuation
Is Abbott India undervalued compared to its fair value and its price relative to the market?
56.55x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 500488 (₹19100.1) is trading above our estimate of fair value (₹17127.75)
Significantly Below Fair Value: 500488 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 500488 is poor value based on its PE Ratio (56.6x) compared to the Indian Pharmaceuticals industry average (21.6x).
PE vs Market: 500488 is poor value based on its PE Ratio (56.6x) compared to the Indian market (18.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 500488's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 500488 is overvalued based on its PB Ratio (16.8x) compared to the IN Pharmaceuticals industry average (2.8x).
Future Growth
How is Abbott India forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
20.5%
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Abbott India has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Abbott India performed over the past 5 years?
20.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 500488 has high quality earnings.
Growing Profit Margin: 500488's current net profit margins (15.5%) are lower than last year (15.8%).
Past Earnings Growth Analysis
Earnings Trend: 500488's earnings have grown significantly by 20.6% per year over the past 5 years.
Accelerating Growth: 500488's earnings growth over the past year (9%) is below its 5-year average (20.6% per year).
Earnings vs Industry: 500488 earnings growth over the past year (9%) underperformed the Pharmaceuticals industry 30.2%.
Return on Equity
High ROE: 500488's Return on Equity (29.8%) is considered high.
Financial Health
How is Abbott India's financial position?
Financial Position Analysis
Short Term Liabilities: 500488's short term assets (₹33.3B) exceed its short term liabilities (₹10.9B).
Long Term Liabilities: 500488's short term assets (₹33.3B) exceed its long term liabilities (₹2.2B).
Debt to Equity History and Analysis
Debt Level: 500488 is debt free.
Reducing Debt: 500488 had no debt 5 years ago.
Debt Coverage: 500488 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 500488 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Abbott India current dividend yield, its reliability and sustainability?
1.44%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 500488's dividend (1.44%) is higher than the bottom 25% of dividend payers in the Indian market (0.37%).
High Dividend: 500488's dividend (1.44%) is low compared to the top 25% of dividend payers in the Indian market (1.51%).
Stability and Growth of Payments
Stable Dividend: 500488's dividends per share have been stable in the past 10 years.
Growing Dividend: 500488's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (35.5%), 500488's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.6yrs
Average board tenure
CEO
Anil Joseph (46 yo)
1.33yrs
Tenure
₹38,000,000
Compensation
Mr. Anil Joseph serves as Managing Director and Director at Abbott India Limited since July 01, 2020. He worked with reputable companies across different business sectors (predominately Healthcare & FMCG)...
CEO Compensation Analysis
Compensation vs Market: Anil's total compensation ($USD505.91K) is below average for companies of similar size in the Indian market ($USD892.88K).
Compensation vs Earnings: Insufficient data to compare Anil's compensation with company performance.
Board Members
Experienced Board: 500488's board of directors are considered experienced (3.6 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Abbott India Limited's employee growth, exchange listings and data sources
Key Information
- Name: Abbott India Limited
- Ticker: 500488
- Exchange: BSE
- Founded: 1944
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: ₹405.864b
- Shares outstanding: 21.25m
- Website: https://www.abbott.co.in
Number of Employees
Location
- Abbott India Limited
- Godrej BKC
- 16th Floor, Plot C, “G” Block
- Mumbai
- Maharashtra
- 400051
- India
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/11/30 15:56 |
| End of Day Share Price | 2021/11/30 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2021/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.